News - Lederle Laboratories
2005-11-21 09:00:33
AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that two leading executives from the vaccine industry have joined AVANT's Board of Directors. Alf A. Lindberg, M.D., Ph.D.
AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that two leading executives from the vaccine industry have joined AVANT's Board of Directors. Alf A. Lindberg, M.D., Ph.D.